Reply to 'Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors' (Haemophilia 2009; 15: 3-10)

Haemophilia. 2010 Mar;16(2):372-3. doi: 10.1111/j.1365-2516.2009.02151.x. Epub 2009 Dec 17.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Blood Coagulation Factors / therapeutic use*
  • Factor VIIa / therapeutic use
  • Hemophilia A / drug therapy*
  • Hemostasis / drug effects
  • Humans
  • Male
  • Recombinant Proteins / therapeutic use

Substances

  • Blood Coagulation Factors
  • Recombinant Proteins
  • prothrombin complex concentrates
  • Factor VIIa